Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel agents with potential in the treatment of anxiety, depression, etc. revealed in recent patents

Jan. 9, 2006

Method for diagnosis/prognosis of wound infection claimed in Ethicon patent

Jan. 5, 2006

sanofi-aventis prepares and tests new histamine H3 receptor antagonists

Jan. 5, 2006

New quinolone antibacterials emerge from Pfizer R&D

Jan. 5, 2006

New agents with activity against HIV reported in patent literature

Jan. 4, 2006

New agents and strategies for respiratory disorders

Jan. 4, 2006

Novel chemokine CCR2B antagonists from AstraZeneca

Jan. 3, 2006

New agents for endocrine-related disorders disclosed in recent patent literature

Jan. 3, 2006

New histamine H3 receptor ligands emerge from Banyu R&D

Jan. 2, 2006

Novel agents with potential for the treatment of anxiety, depression, etc.

Jan. 2, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...